Correction: Inhibition of HIF-1α By PX-478 Enhances the Anti-Tumor Effect of Gemcitabine by Inducing Immunogenic Cell Death in Pancreatic Ductal Adenocarcinoma

Oncotarget - United States
doi 10.18632/oncotarget.27205
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

The BET Inhibitor I-Bet762 Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation and Enhances the Therapeutic Effect of Gemcitabine

Scientific Reports
Multidisciplinary
2018English

The Anti-Fibrotic Effect of GV1001 Combined With Gemcitabine on Treatment of Pancreatic Ductal Adenocarcinoma

Oncotarget
Oncology
2016English

DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma

PLoS ONE
Multidisciplinary
2012English

Tumour-Derived Interleukin 35 Promotes Pancreatic Ductal Adenocarcinoma Cell Extravasation and Metastasis by Inducing ICAM1 Expression

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

ST6Gal-I Sialyltransferase Promotes Chemoresistance in Pancreatic Ductal Adenocarcinoma by Abrogating Gemcitabine-Mediated DNA Damage

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

5-Azacytidine Potentiates Anti-Tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma

Frontiers in Immunology
AllergyImmunology
2020English

Tumor-Stroma Interactions in Pancreatic Ductal Adenocarcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.

Current Molecular Medicine
BiochemistryMedicineMolecular MedicineMolecular Biology
2016English

YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine

Nutrients
NutritionFood ScienceDietetics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy